Clinical Trial Update: Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dose-attenuated chemotherapy in compromised patients with lung cancer is currently recruiting. The study includes both small-cell and n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Lung Cancer, Small-cell Lung Cancer | Phase 2 | Status: RECRUITING